1348 related articles for article (PubMed ID: 15652751)
1. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
[TBL] [Abstract][Full Text] [Related]
2. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.
Koivunen P; Hirsilä M; Remes AM; Hassinen IE; Kivirikko KI; Myllyharju J
J Biol Chem; 2007 Feb; 282(7):4524-4532. PubMed ID: 17182618
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
[TBL] [Abstract][Full Text] [Related]
5. Activation of hypoxia-induced transcription in normoxia.
Hägg M; Wennström S
Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
[TBL] [Abstract][Full Text] [Related]
6. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.
Selak MA; Durán RV; Gottlieb E
Biochim Biophys Acta; 2006; 1757(5-6):567-72. PubMed ID: 16797480
[TBL] [Abstract][Full Text] [Related]
7. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.
Demidenko ZN; Rapisarda A; Garayoa M; Giannakakou P; Melillo G; Blagosklonny MV
Oncogene; 2005 Jul; 24(30):4829-38. PubMed ID: 15897903
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
10. Proline hydroxylation and gene expression.
Kaelin WG
Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
[TBL] [Abstract][Full Text] [Related]
11. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
12. OS-9: another piece in the HIF complex story.
Flashman E; McDonough MA; Schofield CJ
Mol Cell; 2005 Feb; 17(4):472-3. PubMed ID: 15721249
[TBL] [Abstract][Full Text] [Related]
13. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Masson N; Ratcliffe PJ
J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
[TBL] [Abstract][Full Text] [Related]
14. Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase.
Temes E; Martín-Puig S; Acosta-Iborra B; Castellanos MC; Feijoo-Cuaresma M; Olmos G; Aragonés J; Landazuri MO
J Biol Chem; 2005 Jun; 280(25):24238-44. PubMed ID: 15849364
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factors in the first trimester human lung.
Groenman F; Rutter M; Caniggia I; Tibboel D; Post M
J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1 (HIF-1) pathway.
Semenza GL
Sci STKE; 2007 Oct; 2007(407):cm8. PubMed ID: 17925579
[TBL] [Abstract][Full Text] [Related]
17. A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases.
Cho H; Park H; Yang EG
Biochem Biophys Res Commun; 2005 Nov; 337(1):275-80. PubMed ID: 16182243
[TBL] [Abstract][Full Text] [Related]
18. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
[TBL] [Abstract][Full Text] [Related]
19. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.
Pan Y; Mansfield KD; Bertozzi CC; Rudenko V; Chan DA; Giaccia AJ; Simon MC
Mol Cell Biol; 2007 Feb; 27(3):912-25. PubMed ID: 17101781
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
